Introduction steps are coupled in the overall vacuole fusion reaction; current studies of LMA1 (below) are providing insights Subcellular organelles are inherited rather than syntheinto this mechanism. sized de novo during cell division (Warren and Wickner, LMA1 (low Mr activity #1), a novel trafficking factor, is 1996). We have studied the inheritance of the vacuoles a heterodimer of thioredoxin and proteinase B inhibitor 2 (lysosomes) of Saccharomyces cerevisiae. Early in S (I B 2 ) (Xu and Wickner, 1996; Xu et al., 1997) . These two phase, the vacuole projects a tubular-vesicular "segrecytosolic proteins (Maier et al., 1979) were not previously gation" structure into the newly formed bud (Weisman known to be associated. Both subunits are needed for and Wickner, 1988; Gomes de Mesquita et al., 1991;  efficient vacuole inheritance in vivo and for the LMA1 Raymond et al., 1992) . Through this segregation strucactivity in cell extracts. In vivo studies showed that deleture, the bud receives maternal vacuolar vesicles, which tion of both yeast thioredoxin genes caused 47% of fuse to establish the daughter vacuoles. In vac mutants, cells with large buds to have no bud vacuole (versus only many large buds lack a vacuole entirely or have only an 2.4% in wild type; Xu and Wickner, 1996) , and deletion of unusually small organelle (Weisman et al., 1990; Shaw I B 2 caused 35% of cells with large buds to have no bud and Wickner, 1991; Nicolson et al., 1995; vacuole (versus 2.7% in wild type; Xu et al., 1997) . Even 1996) . Vacuole inheritance can also be studied in vitro those thioredoxin-deficient yeast that had a bud vacuole (Conradt et al., 1992 (Conradt et al., , 1994 Haas et al., 1994) . Isolated showed unusually small bud vacuole diameters (Xu and vacuoles, when incubated with ATP and cytosol, form Wickner, 1996) . Though we have only assayed the role segregation structures and undergo fusion. This reacof LMA1 in the final, fusion step of vacuole inheritance, tion is abolished when its components are prepared its absence clearly affects the overall inheritance profrom vac mutants, establishing its authenticity (Haas et cess, suggesting a coupling between the delivery of al., 1994; Nicolson et al., 1995) . vacuolar material to the bud and fusion in the bud. Each The final step of the vacuole inheritance reaction is LMA1 subunit acts via a novel mechanism, as the thiorehomotypic vacuole fusion. Like many membrane trafdoxin subunit is not acting through redox chemistry, ficking and fusion processes, this requires Sec18p/NSF and the protease B inhibitor activity of I B 2 is not related (N-ethylmaleimide sensitive fusion protein), Sec17p/␣-to its ability to promote vacuole fusion (Slusarewicz et SNAP (soluble NSF attachment protein) , and the SNAREs al., 1997; Xu et al., 1997) . Using salt-washed vacuoles, (SNAP receptors) Vam3p (t-SNARE) and the in vitro fusion reaction requires the addition of only (Rothman, 1994; Haas and Wickner, 1996; two soluble proteins, Sec18p and LMA1 . NSF is an oligomeric ATPase (Whiteheart et Both Sec18p and LMA1 act early in the in vitro reaction. al., 1994) that requires SNAPs to bind to the SNAREs
The action of Sec18p leads to Sec17p release from vacu- (Sö llner et al., 1993 , 1997) . We now report that LMA1 undergoes a biochemically defined cycle on vacuoles during the in vitro reaction. LMA1 employs Sec18p as its receptor for nucleotide-independent binding to vacuole membranes; the combination of the sec18-1 mutation and deletion of the I B 2 subunit of LMA1 causes a striking synthetic phenotype of vacuole fragmentation. After Sec18p hydrolyzes ATP, the bound LMA1 is transferred to a complex that includes the activated Vam3p (t-SNARE) to stabilize its labile, primed state. Although some reagents that block docking or fusion do not block the release of LMA1 from vacuoles, Microsystin-LR, a Ser/Thr protein phosphatase inhibitor, blocks both fusion and LMA1 release in an ATP-dependent manner. Thus, LMA1 links the action of Sec18p/Sec17p to the activation of Vam3p and finally to fusion.
Results
In vitro vacuole fusion is assayed with purified vacuoles from two different strains. Vacuoles isolated from BJ3505 lack proteases A and B and therefore contain a catalytically inactive form of proalkaline phosphatase, whereas vacuoles from DKY6281 contain normal vacuolar proteases but have no alkaline phosphatase due to a deletion in the PHO8 gene. Upon fusion of vacuoles isolated from these two strains, the vacuolar lumenal contents are mixed, and the proteases from one fusion partner cleave the proalkaline phosphatase from the other to yield the active enzyme, allowing quantitative assay of fusion.
LMA1 Binds to Vacuoles and Is Released during a Normal Incubation
Homotypic fusion between salt-washed vacuoles requires the addition of only two purified soluble proteins, Sec18p and LMA1 . ATP hydrolysis by (A and B) For each timepoint, a fusion reaction corresponding to Sec18p triggers the release of Sec17p from the vacuoles six standard reactions was incubated at 25ЊC. Aliquots equivalent (Mayer et al., 1996) , creating an activated, labile state to one standard reaction were used to measure fusion by alkaline phosphatase assay (A), and others, equivalent to five standard reacof vacuoles that is stabilized by LMA1 .
tions, were used to measure bound LMA1 (B).
To explore LMA1 function, salt-washed vacuoles were (C) Nonradioactive LMA1 (0-682 nM) was added to tubes containing incubated with Sec18p, LMA1, and ATP at 25ЊC. At difa standard reaction and a constant amount of iodinated LMA1 (11 ferent times, aliquots were either transferred to ice and nM) prior to addition of vacuoles. After 15 min on ice, vacuoles were assayed for the fusion that had occurred or centrifuged centrifuged (10,000 ϫ g, 10 min, 4ЊC) and washed twice with 500 to assay the bound LMA1 by SDS-PAGE and immul of 0% Ficoll containing 1ϫ PIC, and the pellet radioactivity was determined. Scatchard analysis was as described in Hartl et al. noblotting with anti-Trx1p antibodies. Fusion continued (1990). for 90 min ( Figure 1A ). Though salt-washed vacuoles initially had no LMA1 ( Figure 1B , lane "vac"), LMA1 binds rapidly and is released after about 40 min ( Figure 1B Thioredoxin did not compete with LMA1 for binding to vacuoles (data not shown). These data suggest that antibodies (data not shown). LMA1 binds to salt-washed vacuoles at saturable high-affinity sites with a Kd ϭ 1.3 ϫ once LMA1 binds to saturable, high-affinity receptor(s) on vacuoles, it undergoes a specific reaction that regu-10 Ϫ8 M ( Figure 1C ). To study LMA1 binding and release, we incubated lates its release. Since Vam3p (t-SNARE) and Nyv1p (v-SNARE) are vacuoles with Sec18p, LMA1, and ATP on ice. An excess of I B 2 was added to the reaction either at 0 min (before required for vacuole inheritance and fusion (Nichols et al., 1997) , we tested whether they are needed for LMA1 LMA1 binding to vacuoles) or at 10 min (after LMA1 had bound to vacuoles), and the reactions were transferred binding to vacuoles. Vacuoles were isolated from ⌬vam3, ⌬nyv1, ⌬vam3⌬nyv1, and wild-type strains and to 25ЊC for a second incubation. When excess I B 2 was added at the beginning of an incubation, it fully comthe vacuolar components were analyzed by immunoblotting. The vacuolar protein Vma1p was used as a peted for LMA1 binding sites (Figure 2A , open squares).
of Sec18p/Sec17p sites by the antibodies, since antiSec17p (see Figure 6 , below) and anti-Ypt7p antibodies (see Figure 7 , below) do not inhibit LMA1 binding. These data indicate that Sec18p is the receptor for LMA1 binding to vacuoles. As a further test, we incubated 125 I-LMA1 with His 6 -tagged Sec18p without ATP, precipitated the Sec18p with Ni-beads, and quantified the radioactivity on the beads by ␥ counting.
125 I-LMA1 bound to the beads via His 6 -tagged Sec18p ( Figure 3B , lanes 1 and 2), and this binding was sensitive to imidazole (lanes 3 and 4) but not to NaCl (lanes 5 and 6). Thus, Sec18p and LMA1 interact directly. This interaction is also seen through anti-Trx1p coimmunoprecipitation of Sec18p from detergent-solubilized vacuolar membranes (Figure 6, below) . This binding serves to regulate Sec18p action, as both Sec17p and LMA1 are needed for activation of the ATPase activity of Sec18p ( Figure 3C ). Thus, Sec18p is the major receptor for LMA1 binding to vacuolar membranes, and the catalytic activity of Sec18p is regulated by its cochaperones, Sec17p and LMA1.
To test whether the physical ( Figure 3B ) and functional ( Figure 3C ) interactions between Sec18p and LMA1 seen in vitro are important for vacuole fusion in the intact cell, we examined the morphology of vacuoles in wild-type cells and isogenic strains with either the sec18-1 temperature-sensitive mutation, with deletion of PBI2, the gene that encodes the small subunit of LMA1, or with both sec18-1 and ⌬pbi2. Deletion of I B 2 abolishes LMA1 activity in vitro and confers a partial vacuole inheritance defect. At 25ЊC, the vacuoles of ⌬pbi2 cells are indistinguishable from wild-type (Figures ( Figure 4C ). We constructed four isogenic strains: wild type, ⌬pbi2, ⌬yhr138c, and ⌬pbi2⌬yhr138c. Neither demarker to normalize the amount of vacuolar material.
letion of PBI2 nor of YHR138c alone affected vacuole Both LMA1 and Sec18p appeared on wild-type, ⌬vam3, morphology, but the double deletion showed a striking ⌬nyv1, or ⌬vam3⌬nyv1 vacuoles in comparable amounts synthetic phenotype of highly fragmented vacuoles (Fig-(Figure 2B ). This suggests that both Sec18p and LMA1 ures 4D and 4E), indicating faulty vacuole fusion. While can employ receptors other than Vam3p/Nyv1p for bindfurther studies of p13 are needed to establish its roles ing to the vacuoles.
in Sec18p catalysis and organelle trafficking, the redundancies of the two yeast thioredoxins and of I B 2 and Sec18p Is the Vacuole Receptor for LMA1 p13 explains why recessive mutants in LMA1 were not Both Sec18p and LMA1 act at an early stage of in vitro discovered in the initial sec screens. vacuole fusion , and both are present on ⌬vam3 ⌬nyv1 vacuolar membranes ( Figure 2B ). To test whether Sec18p itself is the receptor for LMA1, we Bound LMA1 Is Transferred to a Complex with Vam3p (t-SNARE) upon ATP incubated vacuoles at 25ЊC with Sec18p, LMA1, and ATP, with no Sec18p or with anti-Sec18p antibodies.
Hydrolysis by Sec18p
Though LMA1 binding to vacuoles does not require nuAt different times, aliquots were centrifuged and the vacuole-bound LMA1 was assayed. LMA1 binding recleotides (see Figures 5A and 6A, below), the release of bound LMA1 requires ATP hydrolysis ( Figure 3A ). To quires Sec18p and is blocked by anti-Sec18p antibodies ( Figure 3A ). This block is not due to nonspecific shielding study this ATP requirement, vacuoles were incubated with Sec18p, LMA1, and with or without ATP at 25ЊC. LMA1 binding and release occured normally in the incubations with ATP ( Figure 5A , lanes 1-3), but the LMA1 bound to vacuoles and was not released without ATP (lanes 4-6). In lane 7, the initial mixture containing vacuoles, Sec18p, LMA1, and ATP was incubated at 25ЊC for 10 min, then mixed with apyrase to hydrolyze the free ATP, and the reaction was continued at 25ЊC for a total incubation period of 45 min. The LMA1 that was bound at 10 min (lane 2) was released in the second incubation in the absence of free ATP (lane 7; compare to lanes 3 and 6). Thus, the ATP requirement for LMA1 release is fulfilled in the first 10 min of the incubation, well before the LMA1 is actually released from the vacuoles. The in vitro vacuole fusion reaction becomes resistant to anti-Sec18p antibodies after only 10 min of incubation (Mayer et al., 1996) . To determine whether Sec18p action is required for LMA1 release, vacuoles were incubated with Sec18p, LMA1, and ATP on ice or at 25ЊC for 10 min, and aliquots were centrifuged to measure the bound LMA1. Comparable amounts of LMA1 were bound to vacuoles after 10 min on ice or at 25ЊC ( Figure  5B , lanes 1 and 4). The remaining portions received anti-Sec18p antibodies or the antibody buffer and were further incubated for a total time at 25ЊC of 45 min. Without anti-Sec18p antibodies, the bound LMA1 was released in the second incubation ( Figure 5B , lanes 2 and 5). When vacuoles were first incubated on ice (Figure 5B , lanes 1-3) to allow only LMA1 binding (lane 1), LMA1 release during subsequent incubation at 25ЊC (lane 2) was blocked by anti-Sec18p antibodies (lane 3). However, if the vacuoles had first been incubated for 10 min at 25ЊC (lanes 4-6), the bound LMA1 (lane 4) had reached a reaction stage in which its release (lane 5) was not affected by antibody addition (lane 6). These data indicate that both Sec18p and ATP are required for the release of bound LMA1 from the vacuoles but that neither the ATP ( Figure 5A ) nor Sec18p ( Figure 5B ) is required after a 10 min incubation at 25ЊC for this release. Since ATP is required in the fusion reaction for hydrolysis by Sec18p (Mayer et al., 1996) , we conclude that ATP hydrolysis transfers LMA1 from its Sec18p receptor to a second binding site on the vacuoles.
Since LMA1 is bound to Sec18p then undergoes Sec18 and ATP-dependent transfer in the first 10 min whereas LMA1 release takes 30-40 min, LMA1 may play asked whether LMA1 interacts with a SNARE complex (B) 125 I-labeled LMA1 (10 ng) was mixed (lanes 2, 4, and 6) with 10 component. Vacuoles were incubated with Sec18p, activity was determined as described (Lill et al., 1990 ). The back-1 mM ATP, 2 mM DTT, 0.1ϫ PIC) in the presence of 2 g/ml of ground signal from reactions incubated with Sec18p and ATP on purified His 6 -Sec18p and the indicated concentrations of LMA1 and ice was subtracted. was bound to and released from vacuoles in the complete incubation ( Figure 6A , open circles) and in the incubation with anti-Sec17p antibodies ( Figure 6A , closed circles). With anti-Vam3p antibodies in the absence of ATP, LMA1 bound to the vacuoles but was not released 619; also, each of these transformed to be ⌬pbi2::URA3) were grown at 25ЊC in YPD medium to early log phase. Cells from 1 ml of each culture were harvested (3000 g, 5 min, 4ЊC), resuspended in 1 ml of YCM medium, and stained with FITC (Molecular Probes Inc., Eugene, OR) for fluorescence microscopy (Xu and Wickner, 1996 ␣ ura3-5, his3-11, leu2-3, can R , and transformants ⌬pbi2::URA3, ⌬yhr138c::HIS3, or both) were grown at 30ЊC in YCM to early log phase. Cells were harvested, and vacuoles were stained and visualized as in (A). Deletion of YHR 138c was by replacement with HIS3 by standard methods (Ausubel et al., 1997) . Primers (GIBCO/BRL) for PCR amplification of HIS3 contained either 50 bases prior to the initiation codon of YHR 138c or 50 bases after the stop codon. The PCR products were transformed into either the wild-type or PBI2 deletion strain (Schu et al., 1991) . Transformants were selected for growth on SD minus His plates, and the deletion of YHR138c was verified by PCR using primers 5Ј-GTGTTATTTGCAT ATCATATATAA-3Ј (upstream of YHR138c), 5Ј-CGATGGAGAGAACA AATGGA-3Ј (downstream of YHR138c), and 5Ј-GCCAGTAGGGCCT CTTTA-3Ј (middle of HIS3). -type, sec18-1, ⌬pbi2, or sec18-1 ( Figure 6A , closed squares), demonstrating that the antiVam3p antibodies do not block the initial binding of LMA1. This is consistent with the observation that normal levels of LMA1 are bound to vacuoles that lack one or both SNAREs ( Figure 2B) . Strikingly, the anti-Vam3p antibodies completely block the stable association of LMA1 with the vacuoles when ATP is present ( Figure  6A , open squares). This suggests that LMA1 initially binds to vacuoles at Sec18p (Figure 3 ) and is transferred by Sec18p and ATP action ( Figure 5 ) to a complex that includes the t-SNARE Vam3p. When Vam3p is complexed with antibodies ( Figure 6A ), there is no second binding site for LMA1 on the vacuoles, and it is released into the supernatant after the Sec18p and ATP reaction. Since Sec18p activates Vam3p (Ungermann et al., 1998), LMA1 may stabilize labile vacuoles through its ATP-dependent release from Sec18p and transfer to a complex that includes this vacuolar t-SNARE. This working model was tested by coimmunoprecipitation. Vacuoles were incubated with or without ATP at 25ЊC for 15 min, extracted with detergent, and immunoprecipitated with immobilized anti-Trx1p antibodies. Without exposure to ATP, the anti-Trx1p antibodies coimmunoprecipitated Sec18p, the v-SNARE Nyv1p, and the t-SNARE Vam3p ( Figure 6B ). This confirms that LMA1 physically interacts with Sec18p ( Figure 3B ) and suggests that Sec18p, Nyv1p, Vam3p, and LMA1 are together in a complex prior to the action of Sec18p and ATP. When the vacuoles had been incubated with ATP, anti-Trx1p antibodies coimmunoprecipitated the t-SNARE Vam3p from detergent extracts ( Figure 6B ). However, there was no detectable Sec18p in the immunoprecipitate, and a reduced amount of Nyv1p remained in the LMA1-Vam3p complex ( Figure 6B ). Thus, as Sec18p hydrolyzes ATP and disassembles the SNARE complex (Ungermann et al., 1998), Sec18p-bound LMA1 is transferred to a complex that includes Vam3p. A quantitative kinetic analysis showed that LMA1 remained in a complex that includes Vam3p after the initial SNARE complex was disrupted ( Figure 6C ). After 20 min, as the LMA1 is released from the vacuoles, its association with Vam3p is perforce lost as well.
To establish that these LMA1-SNARE complexes had formed on the vacuoles and not simply in the detergent extract, vacuoles were either incubated with LMA1 and merely in detergent solution. We conclude that LMA1 is transferred from Sec18p in the SNARE complex to a subcomplex that contains Vam3p and suggest that it functions to stabilize the labile primed vacuoles via its interaction with this Vam3p complex.
The Release of LMA1 and Vacuole Fusion Are Mediated by an Unknown Phosphoprotein
The release of LMA1 from the vacuoles (Figure 1) is not affected by antibodies to Sec17p (Figure 6 ), though these antibodies block docking and fusion (Mayer et al., 1996; Mayer and Wickner, 1997) . Furthermore, neither Gdi1p nor antibodies to Ypt7p, which block docking, nor GTP␥S, which blocks fusion , affects the binding and release cycle of LMA1 ( Figure 7A ). These data suggest that neither docking nor fusion per se causes LMA1 release. Rather, LMA1 release may be regulated by a factor which itself governs the docking or fusion reaction. In line with this concept, we find that Microcystin-LR, a potent inhibitor of protein phosphatases 1 and 2A (Honkanen et al., 1990) , which blocks vacuole fusion (Conradt et al., 1994; Mayer et al., 1996; Mayer and Wickner, 1997) , also inhibits the release of LMA1 ( Figure 7A ). To investigate how Microcystin-LR inhibits LMA1 release, vacuoles were incubated with Sec18p, LMA1, and ATP at 25ЊC for 20 min to allow priming and docking, then reisolated and resuspended for a second incubation at 25ЊC for 70 min. After the second incubation, each reaction was divided into two portions. One was assayed for the fusion that had occurred ( Figure 7B ) and the other for LMA1 release ( Figure 7C ). The lanes a and b in Figure 7B show an ice control and a complete vacuole fusion reaction. After the first incubation (25ЊC, 20 min), ‫%52ف‬ of total fusion had occurred ( Figure 7B , lane 1 versus lane b) and LMA1 had bound to the vacuoles ( Figure 7C, lane 1) . In the second incubation, neither ATP nor apyrase affects either the fusion reaction (Figure 7B, lanes 2, 4, and 6 ) or LMA1 release ( Figure 7C , lanes 2, 4, and 6), in agreement with earlier observations ( Figure 5 ; Conradt et al., 1994; Xu et al., 1997) . When ATP was added, ensuring a high ATP concentration, Microcystin-LR blocked both fusion ( Figure 7B free ATP. These data suggest that both LMA1 release Samples (lanes 1-7) equivalent to six standard fusion reactions were and fusion are regulated by an unknown phosphoproincubated at 25ЊC for 20 min (first incubation). The vacuoles were tein(s) and require an ATP-dependent phosphatase acthen reisolated (10,000ϫ g, 5 min, 4ЊC), resuspended as indicated, tivity to keep this target in a dephosphorylated state. The and divided into two groups. In one group (B), each sample contained vacuoles equivalent to one standard fusion reaction. In the observation that GTP␥S does not block LMA1 release other group (C), each sample contained vacuoles equivalent to five ( Figure 7A ), though it does block fusion (Haas et al., standard fusion reactions. The reactions were incubated at 25ЊC for 1994; Mayer et al., 1996) , suggests that LMA1 release 70 min (second incubation) and then assayed for fusion activity (B) occurs before or in parallel with a reaction that is sensior for bound LMA1 (C). The fusion that had occurred after the first tive to GTP␥S. Since, as shown in Figure 1 trigger fusion.
Discussion
act to stabilize the activated t-SNARE? Yeast protein disulfide isomerase (PDI) has both thioredoxin-like redox activity and a chaperone-like activity (Freedman LMA1 is a novel trafficking factor that is required for vacuole inheritance and fusion, both in vivo and in vitro et al., 1994) . Interestingly, the function of PDI that is essential for cell viability does not reside in its isomerase (Xu and Wickner, 1996; Xu et al., 1997) . To fulfill its function, LMA1 binds to vacuoles and is released in a activity but rather depends on its chaperone-like peptide-binding domain (LaMantia and Lennarz, 1993) . Howdefined cycle. LMA1, using Sec18p as its receptor, binds to the vacuole membrane at high-affinity sites comever, the chaperone activity of PDI is independent of its thioredoxin-like active site (Quan et al., 1995; Yao et al., prised of Sec18p, Sec17p, Vam3p , and Nyv1p, the vacuole "SNARE complex." Upon ATP hydrolysis by Sec18p, 1997) . Thioredoxin binds to coliphage T7 polymerase like a "cap," conferring processivity to T7 replication promoted by Sec17p and LMA1, this complex is disassembled (Ungermann et al., 1998) , Sec17p is released without redox chemistry (Huber et al., 1986) . Since the redox activity of the thioredoxin subunit of LMA1 is also (Mayer et al., 1996) , and LMA1 is transferred to its second binding site, a complex that includes the activated not required for vacuole fusion and since LMA1 binds to and stabilizes the activated t-SNARE, we suggest t-SNARE Vam3p, to stabilize the primed and labile vacuoles . We suggest that the lability of that LMA1 may also act in a chaperone-like fashion, preserving the active t-SNARE conformation. primed vacuoles for fusion may largely be a lability of the activated t-SNARE and that a major function of LMA1 LMA1 is released from vacuoles at fusion. Though little is known of the proteins that catalyze the fusion of is to stabilize this SNARE. After v/t-SNARE pairing and prior to fusion, an unidentified phosphoprotein is dedocked vacuoles, fusion is inhibited by GTP␥S (Haas et al., 1994; Mayer et al., 1996) , suggesting regulation by phosphorylated by a (Microcystin-LR sensitive) phosphatase, allowing the release of LMA1 from the vacua G protein other than Ypt7p. Though LMA1 is released from the vacuoles at a late stage of the reaction ( Figure  oles , completing its cycle. Release may even initiate the fusion of vacuoles, though further studies are required 1), release is not blocked by GTP␥S, nor even by antiSec17p or Gdi1p (Figures 6 and 7) , agents that block to test this concept. Clearly the catalytic cycle of LMA1 explains how the priming action of Sec18p, Sec17p, both docking and fusion (Mayer et al., 1996; Mayer and Wickner, 1997) . Nevertheless, LMA1 release is reguand ATP is coupled to the stabilization of the activated t-SNARE. lated, as it is blocked by Microcystin-LR, and this block is only seen with ATP ( Figure 7) . The block to fusion by The LMA1 cycle is intimately linked to the action of Sec18p, as revealed by the sensitivity of successive Microcystin-LR shows a similar ATP requirement ( Figure  7 ). Fusion is not needed for LMA1 release; rather, we reaction stages to antibodies to Sec18p. Since Sec18p is the membrane receptor for LMA1, the initial binding suggest that LMA1 release regulates fusion and that this release requires the dephosphorylated state of a of LMA1 can be blocked by anti-Sec18p antibodies. After LMA1 has bound to the vacuoles, anti-Sec18p (unidentified) phosphoprotein. Microcystin-LR then blocks the responsible phosphatase; recent studies (G. Eitzen antibodies block the ATP-dependent LMA1 transfer and Sec17p release (Mayer et al., 1996) . After Sec18p hydroand W. W., unpublished data) indicate that this phosphatase may belong to a class (Vogel et al., 1993) that is lyzes ATP and transfers LMA1 to Vam3p, the rest of the LMA1 cycle becomes resistant to anti-Sec18p antibodactivated by ATP and a kinase through its own phosphorylation. ies and no longer needs ATP. Thus, the Sec18p functions include: (1) Sec17p release from the vacuoles, (2) disasIs LMA1 a general factor of vesicular trafficking or specific for the vacuole? Since LMA1 interacts with both sembly of v/t-SNARE complexes, (3) activation of the t-SNARE, and (4) transfer of LMA1 to its second binding Sec18p and a t-SNARE and since a similar NSF/SNAP/ SNARE system is required for many membrane trafficksite, the t-SNARE Vam3p complex.
The activity of LMA1 for vacuole fusion depends on ing pathways, LMA1 or its functional equivalents such as LMA2 (Slusarewicz et al., 1997) and p13 may also neither the redox activity of its thioredoxin subunit nor the proteinase B inhibitory activity of its I B 2 subunit (Sluhave a necessary role in other intracellular trafficking events. Recent studies have shown that LMA1 is also sarewicz et al., 1997; Xu et al., 1997) . Working together with Sec17p, LMA1 stimulates Sec18p ATPase activity required for ER-to-Golgi trafficking (Barlowe, 1997). Us-( Figure 3C ) and rapidly stabilizes the Sec18p-primed, ing a reconstituted system, Barlowe has found that labile vacuoles at an early reaction stage .
LMA1 plays a functional role in the fusion of ER-derived The data presented here further demonstrate that LMA1 vesicles to Golgi membranes after Sec18p action, the functions through interactions with the activated t-SNARE same order as is seen in vacuole fusion (Barlowe, 1997). Vam3p (Ungermann et al., 1998) . Recent studies have LMA1, a novel trafficking factor, is therefore required shown that LMA1 is required for the Sec18p and ATPboth for homotypic vacuole fusion as well as for heteromediated disassembly of a purified, functional SNARE typic ER-to-Golgi membrane traffic. LMA1 or its funccomplex (K. S. and W. W., unpublished data). This actitional homologs may be general factors in intracellular vation event probably involves a conformational change membrane trafficking. of the t-SNARE (Hanson et al., 1995 (Hanson et al., , 1997 after its dissociation from other components such as Sec18p, Sec17p,
Experimental Procedures
and Nyv1p. The lability of primed vacuoles suggests that this activated form of the t-SNARE is very transient.
Strains and Reagents
However, it can be "captured" by LMA1 at or just after PBS. Antiserum (1 ml) was incubated with 0.5 ml of protein A beads on a rocker for 2 hr at room temperature (RT). The beads were described in Nichols et al. (1997) .
Reagents were as described (Xu and Wickner, 1996; collected (10,000 g, 30 s) and twice suspended in 10 vol of 0.2 M sodium borate (pH 9.0), then resuspended in 10 vol of 0.2 M sodium 1997). LMA1, I B 2 , Gdi1p, and His-tagged Sec17p and Sec18p were purified as described (Haas et al., 1995; Haas and Wickner, 1996;  borate (pH 9.0), and dimethylpimelimidate (solid) was added to 20 mM. After incubation on the rocker for 30 min at RT, the beads were Xu and Wickner, 1996; Slusarewicz et al., 1997) .
Recombinant LMA1 was purified from E. coli. Yeast TRX1 and sedimented and suspended in 10 vol of 0.2 M ethanolamine-Cl (pH 8.0) and incubated for 2 hr at RT with gentle mixing. Beads were PBI2 genes were isolated by PCR. Primers (GIBCO/BRL) for PCR amplification of TRX1 were 5Ј-ATAGAAGACTAGACACCTCGATACwashed once with 1ϫ PBS, once with PBS containing 500 mM NaCl, twice with 1ϫ PBS, once with 2% SDS in 100 mM Tris-Cl (pH 8.3), 3Ј and 5Ј-CAAACACAGTATAGAAACACAATATATC-3Ј. Primers for PCR amplification of PBI2 were 5Ј-CATCGGGAACTTCTTTCC-3Ј twice with 1% Triton-100 in 100 mM Tris-Cl (pH 8.3), and three times with 50 mM Tris-Cl (pH 7.5), 50 mM NaCl. and 5Ј-GTGTTTGCGTTTATCTCAGG-3Ј. PCR products were subcloned into pBAD22 (Guzman et al., 1995) and transformed into E.
Vacuoles were reisolated (10 min, 10,000 g, 4ЊC) from a fusion reaction corresponding to 140 g vacuolar protein, resuspended in coli BL21 (DE3). E. coli cells expressing yeast TRX1 and PBI2 were grown in LB medium with 100 g/ml ampicillin to OD ϭ 0.3, then 700 l of 0% Ficoll buffer, resedimented, resuspended in 1 ml of solubilization buffer (10 mM HEPES [pH 7.2], 50 mM NaCl, 5 mM arabinose was added to 2% and the culture continued for 2 hr. Cells were harvested (5000 ϫ g, 4ЊC, 10 min), resuspended in 50 mM Tris-EDTA, 1ϫ PIC, 0.5 mM PMSF, 10% glycerol, 0.2 M sorbitol, and 0.5% digitonin), and incubated on ice for 20 min. Insoluble material Cl (pH 7.5), lysed by French Press (5000 psi, three passages), and centrifuged (260,000 ϫ g, 2 hr, 2ЊC). Clarified lysate (100 ml) was was removed by centrifugation (14,000 g, 15 min, 4ЊC), and 10% of the extract was saved as starting material. To the remainder, 40 l applied to a 10 cm ϫ 54 cm (4 l) Sephacryl S100HR column equilibrated with buffer C (20 mM Tris-OAc [pH 8.3], 5 mM MgCl 2, 0.2 of a suspension (1:1) of the bead-immobilized antibody (above) was added and mixed on a rocker at 4ЊC overnight. The beads were mM MnCl 2) and the column was eluted with buffer C. Fractions (20 ml) were analyzed by SDS-PAGE and LMA1 activity assay. Fractions washed five times with 20 mM Tris-Cl (pH 7.5), 50 mM NaCl. Bound material was eluted with 40 l of 2% SDS at 95ЊC for 5 min, mixed containing LMA1 were pooled (230 ml), adsorbed to Mono Q 10/10 (Pharmacia), and eluted with a KOAc gradient (0-500 mM; 120 ml) with 15 l of 5ϫ SDS sample buffer and analyzed by 12% SDS-PAGE and immunoblotting. in buffer C at 4ЊC.
Other Methods Antibody Production and Purification
Iodination of LMA1 was performed as described in Economou and Antibodies against Trx1p or I B 2 were raised in rabbits using His6-Wickner (1994) and assayed by ␥ counting. Protein was measured tagged Trx1p and I B 2 purified from E. coli (Muller, 1995; Slusarewicz with Bradford reagent (Bio-Rad) with a BSA standard. SDS-PAGE, et al., 1997) . Affinity purification of these antibodies and antibodies High-Tris SDS-PAGE, and immunoblot analysis were described in to Sec17p, Sec18p, Vam3p, Nyv1p, and Ypt7p was described in Xu and Wickner (1996) . Haas and Wickner (1996) .
